LCTX icon

Lineage Cell Therapeutics
LCTX

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$2
10% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
D. Boral Capital
D. Boral Capital
Jason Kolbert
78% 1-yr LCTX win rate
27 Aug ‘25 1 month ago